Aligos Therapeutics ALGS
NASDAQ ALGS
$4.82 -0.14 (-2.82%)
At close: Oct 22, 2026 · 4:00 PM EDT

Aligos Therapeutics (ALGS) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Aligos Therapeutics (ALGS) reported Return on Capital Employed [ROCE] of -212.92% for Q2 2026, down 148.81 percentage points from -64.12% a year earlier and down 33.17 percentage points from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Aligos Therapeutics posted Return on Capital Employed [ROCE] of -151.49%, down 51.40 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for five consecutive years, with a five-year change of -95.79 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -100.09% in FY2024 (-29.70 pp), -70.39% in FY2023 (-8.59 pp), -61.80% in FY2022 (-1.09 pp) and -60.71% in FY2021 (-5.00 pp).
  • The Q2 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q4 2020.
  • Year over year, Return on Capital Employed [ROCE] gained in three of the last eight quarters, with an average year-over-year change of -26.72 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q4 2025 (a gain of 42.06 percentage points); the low point was Q2 2026 (a drop of 148.81 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -179.75% (Q1 2026), -112.92% (Q4 2025) and -86.52% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 17.52%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 17.92%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.28%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 16.76%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 16.66%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -5.97%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 11.86%
10 Aligos Therapeutics 50.28 Mn -278.13 Mn - -212.92%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -212.92%
Mar 31, 2026 -179.75%
Dec 31, 2025 -112.92%
Sep 30, 2025 -86.52%
Jun 30, 2025 -64.12%
Mar 31, 2025 -94.43%
Dec 31, 2024 -154.99%
Sep 30, 2024 -121.79%
Jun 30, 2024 -98.67%
Mar 31, 2024 -71.38%
Dec 31, 2023 -92.98%
Sep 30, 2023 -115.35%
Jun 30, 2023 -97.67%
Mar 31, 2023 -80.97%
Dec 31, 2022 -79.82%
Sep 30, 2022 -79.05%
Jun 30, 2022 -77.02%
Mar 31, 2022 -74.98%
Dec 31, 2021 -61.03%
Sep 30, 2021 -61.50%
API Access

Aligos Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEY